Extraction
Multi-solvent extraction in a custom closed-loop system with high-throughput evaporation and solvent recovery.
Liechtenstein
Extraction and purification for the pharmaceutical industry.
We isolate plant-derived alkaloids and cannabinoids to pharmaceutical purity, in a purpose-built cleanroom facility at the heart of Europe.
cGMPCleanroom built to cGMP specification
ATEXCertified for solvent handling
99.9%+Purity through molecular separation
EEA · CHAccess to the EU single market and to Switzerland
What we do
From botanical raw material to pure active substance.
A closed, controlled process under one roof: extraction, molecular separation and in-house analytics, documented end to end.
Purification
Chromatographic molecular separation that isolates target compounds to pharmaceutical-grade purity.
Analytics
In-house gas chromatography with multi-batch autosampling, supported by spectroscopic methods for identity and purity.
Focus areas
Alkaloids and cannabinoids.
Two of the most valuable classes of plant-derived compounds in medicine, and two of the most demanding to handle well.
- Alkaloids. Isolation and purification of plant alkaloids as starting materials for active pharmaceutical ingredients.
- Cannabinoids. High-purity cannabinoid isolates.
- Method development. Process and analytical method development for new botanical sources.
The facility
A cleanroom complex in the Liechtenstein Rhine valley.
Zoned cleanrooms, ATEX-certified solvent areas and multi-layer access control, built to cGMP specification.
Why Liechtenstein
A stable base in a trusted regulatory environment.
Liechtenstein is part of the European Economic Area and in a customs union with Switzerland: direct access to both markets from one location.
Our facility operates within that framework, close to Europe’s pharmaceutical centres and under the oversight of national authorities.
About Phytal